Clinical Spectrum and Outcomes of Biopsy-Proven Anti-GBM Disease: A Single-Center Case Series (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB148; "All patients received corticosteroids and plasma exchange; 3 received cyclophosphamide and 1 rituximab. Atypical presentations including ANCA double positivity and concurrent IgA nephropathy may occur. Seronegative anti-GBM disease poses a diagnostic challenge and may be missed without kidney biopsy."
Biopsy • Clinical • Acute Kidney Injury • Glioblastoma • Glomerulonephritis • Hematological Disorders • IgA Nephropathy • Lupus Nephritis • Nephrology • Renal Disease
|
|
Ziad Arabi; Hazim Safar Alghamdi; Fayez F. Alhejaili; Ahmad I. Alflaiw
|